Cannabis for Inflammation: CBD, THC, and Anti-Inflammatory Effects

Understanding Inflammation and the Endocannabinoid System

Inflammation is the body's natural immune response to injury, infection, and tissue damage. Acute inflammation is beneficial: it sends immune cells to the affected area to begin healing. Chronic inflammation, however, occurs when this response persists unnecessarily, leading to ongoing tissue damage and contributing to conditions like arthritis, inflammatory bowel disease, cardiovascular disease, and autoimmune disorders.

The endocannabinoid system (ECS) is deeply involved in regulating immune function and inflammatory responses. CB2 receptors, found primarily on immune cells, play a central role in modulating inflammation. When CB2 receptors are activated, they can reduce the production of pro-inflammatory cytokines (signaling molecules that amplify inflammation) and increase the production of anti-inflammatory cytokines.

This regulatory role makes the endocannabinoid system a promising target for managing chronic inflammation. Both plant-derived cannabinoids and terpenes interact with this system in ways that may help restore balance to an overactive inflammatory response.

CBD Anti-Inflammatory Mechanisms

CBD is the most studied cannabinoid for anti-inflammatory properties. Unlike THC, CBD does not bind strongly to CB1 or CB2 receptors directly. Instead, it influences the endocannabinoid system through several indirect mechanisms:

• FAAH inhibition — CBD inhibits fatty acid amide hydrolase, the enzyme that breaks down anandamide. Higher anandamide levels enhance CB2 receptor activation and reduce inflammatory signaling.
• Adenosine receptor activation — CBD activates A2A adenosine receptors, which are known to reduce inflammation when stimulated. This mechanism is particularly relevant for cardiovascular and neuroinflammation.
• PPAR-gamma activation — CBD activates peroxisome proliferator-activated receptor gamma, a nuclear receptor that when activated reduces the expression of inflammatory genes.
• Cytokine modulation — CBD has been shown in laboratory studies to reduce the production of TNF-alpha, IL-6, and other pro-inflammatory cytokines while increasing anti-inflammatory IL-10.

These mechanisms make CBD relevant for both localized inflammation (when applied topically) and systemic inflammation (when taken orally as a tincture or edible).

THC and Inflammation

THC also possesses anti-inflammatory properties, though its mechanism differs from CBD. THC binds directly to both CB1 and CB2 receptors. CB2 activation by THC can reduce immune cell migration to inflammatory sites and decrease the release of pro-inflammatory mediators.

Additionally, THC provides analgesic effects that can help manage the pain that accompanies inflammation. For many patients, a combination of CBD (addressing inflammation at the cellular level) and THC (providing pain relief and additional anti-inflammatory support) may be more effective than either cannabinoid alone.

The trade-off with THC is its psychoactive effects. Patients who need anti-inflammatory support during the day without impairment may prefer CBD-dominant products, reserving THC-containing products for evening use.

Anti-Inflammatory Terpenes

Several cannabis terpenes have demonstrated anti-inflammatory properties in preclinical research:

• Beta-caryophyllene — The most important terpene for inflammation. Beta-caryophyllene is the only terpene known to bind directly to CB2 receptors, producing anti-inflammatory effects without psychoactive response. Found in black pepper, cloves, and many cannabis strains. Some researchers classify it as a dietary cannabinoid due to its CB2 activity.
• Myrcene — Associated with anti-inflammatory and analgesic properties. Myrcene inhibits the production of prostaglandins, a group of inflammatory mediators. It also enhances the effects of other cannabinoids.
• Alpha-pinene — Found in pine trees and rosemary. Research suggests alpha-pinene inhibits NF-kB, a protein complex that controls the transcription of pro-inflammatory genes.
• Linalool — While best known for calming effects, linalool also has anti-inflammatory activity, particularly in models of acute inflammation.
• Humulene — Found in hops and cannabis. Humulene has shown anti-inflammatory effects comparable to dexamethasone in some preclinical models.

Read our complete Terpenes Guide →

Topical vs. Systemic Approaches

The choice between topical and systemic (oral/inhaled) cannabis for inflammation depends on whether the inflammation is localized or body-wide.

Topical Application

Cannabis topicals deliver cannabinoids directly to the area of inflammation through the skin. They are most effective for joint inflammation, muscle inflammation, tendonitis, and localized skin conditions. Topicals do not produce systemic effects or a psychoactive high, making them suitable for any time of day. Apply generously to the affected area and allow 15 to 45 minutes for onset.

Systemic Administration

For conditions involving widespread or internal inflammation (such as inflammatory bowel disease, systemic autoimmune conditions, or generalized joint inflammation), systemic administration via tinctures, edibles, or inhalation delivers cannabinoids throughout the body via the bloodstream. Systemic approaches may be more appropriate when inflammation is not localized to a single area.

Combination Approach

Many patients use both methods simultaneously: a topical for targeted relief on specific joints or muscles, combined with a low-dose tincture or edible for overall systemic anti-inflammatory support.

Read our complete Topicals Guide →

Dosing for Inflammation

• CBD tincture: Start with 15 to 25mg CBD, taken 1 to 2 times daily. Increase by 5 to 10mg every 5 to 7 days if needed. Anti-inflammatory doses of CBD tend to be higher than anxiolytic doses.
• CBD:THC ratio products: A 4:1 or 2:1 CBD:THC ratio may provide enhanced anti-inflammatory effects. Start with the lowest available dose.
• Topicals: Apply a generous amount (dime to quarter-sized) to the affected area. Reapply every 2 to 4 hours as needed. There is no risk of systemic overuse with topicals.
• Beta-caryophyllene-rich strains: Look for strains with beta-caryophyllene as the dominant or secondary terpene for targeted CB2 anti-inflammatory activation.

Integration with Other Anti-Inflammatory Approaches

Cannabis is most effective as part of a comprehensive anti-inflammatory strategy. Consider combining cannabis use with anti-inflammatory dietary practices (omega-3 fatty acids, turmeric, leafy greens), regular low-impact exercise, adequate sleep, stress management, and any conventional medications prescribed by your physician.

If you take NSAIDs (ibuprofen, naproxen) or prescription anti-inflammatory medications, discuss cannabis use with your doctor. There may be additive effects or interactions that affect dosing of your current medications.

Read our Drug Interactions guide →